Sequenom Inc (SQNM)-Medical Equipment-Deals and Alliances Profile

Sequenom Inc (SQNM)-Medical Equipment-Deals and Alliances Profile


  • Products Id :- GDME2674D
  • |
  • Pages: 44
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Summary

Sequenom Inc (Sequenom) is a life sciences company which offers genetic testing that guides reproductive health matters. The company operates CAP (College of American Pathologists) accredited and CLIA (Clinical Laboratory Improvements Amendment) certified molecular diagnostics clinical laboratory (MDCL) that specializes in the field of in prenatal health. Sequenom offers wide collection of carrier status, noninvasive prenatal testing, and diagnostic test options ranging from baby's whole genome assessment to specific conditions identification which allows parents and physicians to select the right test for each pregnancy. The molecular genetic laboratory-developed tests offer early patient management information for geneticists, maternal fetal medicine specialists, and obstetricians as well as patients. Its MDCLs are located at San Diego, California; Raleigh-Durham, North Carolina; and Grand Rapids, Michigan. Sequenom is headquartered in San Diego, California, the US.

Sequenom Inc (SQNM)-Medical Equipment-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

Business Description-A brief description of the company's operations.

Key Employees-A list of the key executives of the company.

Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

Key Competitors-A list of the key competitors of the company.

Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company.



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 5

Sequenom Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 6

Sequenom Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 7

Sequenom Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 8

Sequenom Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 9

Sequenom Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 10

Sequenom Inc, Medical Equipment, Deal Details 11

Asset Purchase 11

Sequenom Acquires Noninvasive Prenatal Testing Intellectual Property from Isis Innovation for USD14.5 Million 11

Sequenom Acquires Molecular Diagnostic Application Patents From Helicos BioSciences For US$1.3 Million 12

Partnerships 13

Sequenom enters into an Agreement with University of California 13

Sequenom Enters into Licensing Agreement with Mayo Medical Labs 13

Sequenom Enters Into Licensing Agreement With Laboratoire Cerba For MaterniT21 PLUS 14

Sequenom Enters Into Licensing Agreement With LifeCodexx 15

Cypher Genomics Enters into Agreement with Sequenom to Develop Next Generation Noninvasive Prenatal Tests 16

Enzo Clinical Labs And Sequenom Enter Into Agreement To Market MaterniT21 Plus 16

Sequenom And CombiMatrix Enter Into Agreement To Market Chromosomal Microarray Analysis For Prenatal Testing 17

New England Biolabs Enters Into Licensing Agreement With Sequenom 18

Equity Offering 19

Sequenom Completes Public Offering Of Common Stock For US$62 Million 19

Debt Offering 20

Sequenom Completes Private Placement Of Notes Due 2017 For US$130 Million 20

Asset Transactions 22

Sequenom Plans to Sell Clinical Genomic Lab in North Carolina 22

Acquisition 22

LabCorp Acquires Sequenom 22

Agena Bioscience Completes Acquisition of Sequenom Bioscience for USD31.8 Million 24

Sequenom Inc-Key Competitors 26

Key Employees 27

Locations And Subsidiaries 28

Head Office 28

Other Locations & Subsidiaries 28

Recent Developments 30

Strategy And Business Planning 30

Mar 02, 2016: Sequenom Announces Contract with Anthem BlueCross 30

Jan 07, 2016: Sequenom Announces Restructuring: Plans Sale Of North Carolina Operations And Initiatives To Improve Efficiencies 31

Financial Announcements 32

May 04, 2016: Sequenom Reports First Quarter 2016 Results 32

Mar 02, 2016: Sequenom Reports 2015 Financial Results 34

Jan 11, 2016: Sequenom Announces Preliminary 2015 Results 36

Corporate Communications 37

Apr 12, 2016: Sequenom Strengthens Executive Team with New Vice President of Sales 37

Legal and Regulatory 38

Jun 27, 2016: The Supreme Court Of The United States Denies Sequenom's Petition Requesting Review Of Decision On '540 Patent 38

Mar 21, 2016: Sequenom Files Petition With the Supreme Court of the United States Requesting Review Of Decision On '540 Patent 39

Product News 40

Feb 25, 2016: Sequenom Laboratories Announces Positive Results from Clinical Validation Study on the MaterniT GENOME Test 40

Jan 11, 2016: Sequenom Provides Update On MaterniT Genome Test 41

Other Significant Developments 42

May 03, 2016: Sequenom Announces In-Network Contracts with Anthem Blue Cross and Blue Shield Plans for Georgia, Indiana, Kentucky, Missouri, Ohio, Virginia and Wisconsin 42

Apr 19, 2016: Sequenom Completes Consolidation of North Carolina Operations 43

Appendix 44

Methodology 44

About GlobalData 44

Contact Us 44

Disclaimer 44

List of Figures

Sequenom Inc, Medical Equipment, Deals by Type, 2011 to YTD 2017 1

Sequenom Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 1

Sequenom Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 1

Sequenom Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 1

Sequenom Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 6

Sequenom Inc, Medical Equipment, Deals by Type, 2011 to YTD 2017 7

Sequenom Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 8

Sequenom Inc, Medical Equipment, Deals by Market, 2011 to YTD 2017 9

List of Tables

Sequenom Inc, Medical Equipment, Key Facts, 2015 1

Sequenom Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 1

Sequenom Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 6

Sequenom Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 7

Sequenom Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 8

Sequenom Inc, Deals By Market, 2011 to YTD 2017 9

Sequenom Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 10

Sequenom Acquires Noninvasive Prenatal Testing Intellectual Property from Isis Innovation for USD14.5 Million 11

Sequenom Acquires Molecular Diagnostic Application Patents From Helicos BioSciences For US$1.3 Million 12

Sequenom enters into an Agreement with University of California 13

Sequenom Enters into Licensing Agreement with Mayo Medical Labs 13

Sequenom Enters Into Licensing Agreement With Laboratoire Cerba For MaterniT21 PLUS 14

Sequenom Enters Into Licensing Agreement With LifeCodexx 15

Cypher Genomics Enters into Agreement with Sequenom to Develop Next Generation Noninvasive Prenatal Tests 16

Enzo Clinical Labs And Sequenom Enter Into Agreement To Market MaterniT21 Plus 16

Sequenom And CombiMatrix Enter Into Agreement To Market Chromosomal Microarray Analysis For Prenatal Testing 17

New England Biolabs Enters Into Licensing Agreement With Sequenom 18

Sequenom Completes Public Offering Of Common Stock For US$62 Million 19

Sequenom Completes Private Placement Of Notes Due 2017 For US$130 Million 20

Sequenom Plans to Sell Clinical Genomic Lab in North Carolina 22

LabCorp Acquires Sequenom 22

Agena Bioscience Completes Acquisition of Sequenom Bioscience for USD31.8 Million 24

Sequenom Inc, Key Competitors 26

Sequenom Inc, Key Employees 27

Sequenom Inc, Other Locations 28

Sequenom Inc, Subsidiaries 28

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

Sequenom Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

select a license

Single User License
USD 250 INR 16065
Site License
USD 500 INR 32130
Corporate User License
USD 750 INR 48195

NEWSLETTER BY CATEGORY




Testimonials

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements....

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ...

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies....

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ...

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!...



Ken Research Pvt. Ltd. Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

query [@] kenresearch.com